Skip to content
10-Q

Quarterly Report

Tango Therapeutics, Inc. TNGX

0000950170-25-102392

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 29, 2025 111.26M sh
Shares Diluted Q2 2025 · Jun 30, 2025 110.54M sh
Shares Diluted Q2 2025 · Jun 30, 2025 110.49M sh
Shares Diluted Q2 2025 · Jun 30, 2024 108.31M sh
Shares Diluted Q2 2025 · Jun 30, 2024 108.69M sh
Capex Q2 2025 · Jun 30, 2025 $675K
Capex Q2 2025 · Jun 30, 2024 $515K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$78.22M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$61.46M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $39.27M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $69.53M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $51.57M
Stockholders Equity Q2 2025 · Jun 30, 2025 $134.95M
Stockholders Equity Q2 2025 · Mar 31, 2025 $166.76M
Stockholders Equity Q2 2025 · Dec 31, 2024 $199.52M
Stockholders Equity Q2 2025 · Jun 30, 2024 $247.67M
Stockholders Equity Q2 2025 · Mar 31, 2024 $264.45M
Stockholders Equity Q2 2025 · Dec 31, 2023 $253.11M
Current Liabilities Q2 2025 · Jun 30, 2025 $40.03M
Current Liabilities Q2 2025 · Dec 31, 2024 $38.17M
Total Liabilities Q2 2025 · Jun 30, 2025 $102.94M
Total Liabilities Q2 2025 · Dec 31, 2024 $116.98M
Current Assets Q2 2025 · Jun 30, 2025 $190.1M
Current Assets Q2 2025 · Dec 31, 2024 $266.34M
Total Assets Q2 2025 · Jun 30, 2025 $237.89M
Total Assets Q2 2025 · Dec 31, 2024 $316.49M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.35
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.71
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.24
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.58
Eps Basic Q2 2025 · Jun 30, 2025 −$0.35
Eps Basic Q2 2025 · Jun 30, 2025 −$0.71
Eps Basic Q2 2025 · Jun 30, 2024 −$0.24
Eps Basic Q2 2025 · Jun 30, 2024 −$0.58
Sga Expense Q2 2025 · Jun 30, 2025 $11.34M
Sga Expense Q2 2025 · Jun 30, 2025 $22.82M
Sga Expense Q2 2025 · Jun 30, 2024 $10.77M
Sga Expense Q2 2025 · Jun 30, 2024 $21.43M
Rd Expense Q2 2025 · Jun 30, 2025 $32.81M
Rd Expense Q2 2025 · Jun 30, 2025 $69.25M
Rd Expense Q2 2025 · Jun 30, 2024 $38.65M
Rd Expense Q2 2025 · Jun 30, 2024 $76.72M
Net Income Q2 2025 · Jun 30, 2025 −$38.85M
Net Income Q2 2025 · Jun 30, 2025 −$78.73M
Net Income Q2 2025 · Mar 31, 2025 −$39.88M
Net Income Q2 2025 · Jun 30, 2024 −$25.55M
Net Income Q2 2025 · Jun 30, 2024 −$63.47M
Net Income Q2 2025 · Mar 31, 2024 −$37.91M
Operating Income Q2 2025 · Jun 30, 2025 −$40.97M
Operating Income Q2 2025 · Jun 30, 2025 −$83.5M
Operating Income Q2 2025 · Jun 30, 2024 −$29.55M
Operating Income Q2 2025 · Jun 30, 2024 −$71.81M
Revenue Q2 2025 · Jun 30, 2025 $3.18M
Revenue Q2 2025 · Jun 30, 2025 $8.57M
Revenue Q2 2025 · Jun 30, 2024 $19.88M
Revenue Q2 2025 · Jun 30, 2024 $26.35M